Experimental chronic fetal hyperglucagonemia stimulates hepatic pathways for amino acid catabolism and gluconeogenesis
Journal of Endocrinology · 01.04.2026 · 269 (1)
DOI: 10.1530/joe-25-0447 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Endocrinology, online erschienen am 15.04.2026. Verfasst von Amelia R Tanner und 7 weiteren Autor:innen. Beteiligte Einrichtung: Perinatal Research Center, Department of Pediatrics - Neonatology, University of Colorado Anschutz School of Medicine, Aurora, Colorado, USA. Hauptthemen laut MEDLINE: Gluconeogenesis, Liver, Amino Acids, Glucagon. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS.
Abstract (Originalsprache)
Glucagon activates amino acid catabolism and gluconeogenesis in adults. Elevated glucagon concentrations in the fetus occur in pregnancy complications, such as fetal growth restriction (FGR) and hypoxia, yet the impact of chronic fetal hyperglucagonemia is unknown. Using chronically catheterized pregnant sheep, glucose tracers, and liver tissue biopsies, we investigated the effects of nine days of glucagon infusion at 5 or 50 ng/kg/min in late-gestation fetal sheep that increased plasma glucagon concentrations by 800%. Glucagon-infused fetuses were euglycemic and exhibited lower plasma and hepatic amino acid concentrations. They also had increased hepatic mRNA expression of amino acid catabolism genes, including ARG2, GLS2, BCAT1, BCAT2, GLUL, HAL, UROC1, and PPARGC1A. Metabolite profiling in liver tissue revealed enrichment of pathways associated with amino acid degradation, elevated tri- and diphosphate nucleotides, and changes in fatty acid metabolites, supporting enhanced hepatic energy metabolism from amino acid oxidation. Hepatic glycogen content was reduced in glucagon-infused fetuses and the gluconeogenic genes PCK1 and G6PC1 were increased, although fetal glucose production was not detected. These findings demonstrate that in the fetal liver, chronic hyperglucagonemia activates amino acid catabolic pathways, indicating a physiological role for glucagon in regulating fetal amino acid homeostasis. These findings have implications for understanding fetal hepatic adaptations during chronic fetal hyperglucagonemia that can occur in the setting of FGR or hypoxia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Perinatal Research Center, Department of Pediatrics - Neonatology, University of Colorado Anschutz School of Medicine, Aurora, Colorado, USA.
- Department of Pediatrics - Neonatology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
- Animal Reproduction and Biotechnology Laboratory, Department of Biomedical Sciences, Colorado State University College of Veterinary Medicine, Fort Collins, Colorado, USA.
ORCID-Profile: Amelia R Tanner, Sarah N Cilvik
Förderung
- NICHD NIH HHS
Zitieren
APA
Tanner, A. R., Cilvik, S. N., Nguyen, M. A., Brown, L. D., Anthony, R. V., Wright, C. J., Wesolowski, S. R., & Rozance, P. J. (2026). Experimental chronic fetal hyperglucagonemia stimulates hepatic pathways for amino acid catabolism and gluconeogenesis. Journal of Endocrinology, 269(1). https://doi.org/10.1530/joe-25-0447
Vancouver
Tanner AR, Cilvik SN, Nguyen MA, Brown LD, Anthony RV, Wright CJ, et al. Experimental chronic fetal hyperglucagonemia stimulates hepatic pathways for amino acid catabolism and gluconeogenesis. Journal of Endocrinology. 2026;269(1). doi:10.1530/joe-25-0447
BibTeX
@article{Tanner2026,
author = {Tanner, Amelia R and Cilvik, Sarah N and Nguyen, Marjorie A and Brown, Laura D and Anthony, Russell V and Wright, Clyde J and Wesolowski, Stephanie R and Rozance, Paul J},
title = {Experimental chronic fetal hyperglucagonemia stimulates hepatic pathways for amino acid catabolism and gluconeogenesis},
journal = {Journal of Endocrinology},
year = {2026},
volume = {269},
number = {1},
doi = {10.1530/joe-25-0447}
}
EUVIMED